AmCad (4188.TWO) monthly revenue, September 2026

AmCad reported revenue of NT$0.00bn for September 2026, down 5.9% from the previous month and down 62.2% from a year earlier. Year-to-date revenue was NT$0.02bn, down 16.9% year on year. It ranked 148 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.00-5.9-62.2